1. Home
  2. GEF vs NAMS Comparison

GEF vs NAMS Comparison

Compare GEF & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greif Inc.

GEF

Greif Inc.

HOLD

Current Price

$66.60

Market Cap

4.2B

Sector

N/A

ML Signal

HOLD

Logo NewAmsterdam Pharma Company N.V.

NAMS

NewAmsterdam Pharma Company N.V.

HOLD

Current Price

$31.25

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GEF
NAMS
Founded
1877
2019
Country
United States
Netherlands
Employees
12000
100
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GEF
NAMS
Price
$66.60
$31.25
Analyst Decision
Hold
Strong Buy
Analyst Count
3
8
Target Price
$73.33
$46.75
AVG Volume (30 Days)
186.8K
852.4K
Earning Date
01-27-2026
05-07-2026
Dividend Yield
3.36%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.85
$25.64
Revenue Next Year
$1.83
$530.85
P/E Ratio
$4.09
N/A
Revenue Growth
N/A
N/A
52 Week Low
$50.23
$14.06
52 Week High
$77.14
$42.00

Technical Indicators

Market Signals
Indicator
GEF
NAMS
Relative Strength Index (RSI) 42.84 50.14
Support Level $64.44 $29.73
Resistance Level $68.14 $31.72
Average True Range (ATR) 1.76 1.69
MACD 0.04 0.19
Stochastic Oscillator 59.22 79.25

Price Performance

Historical Comparison
GEF
NAMS

About GEF Greif Inc.

Greif Inc is a producer of industrial packaging products and services with manufacturing facilities located in many countries. It offers a comprehensive line of rigid industrial packaging products, such as steel, fiber, and plastic drums, rigid intermediate bulk containers, closure systems for industrial packaging products, transit protection products, water bottles and remanufactured and reconditioned industrial containers, and services, such as container life cycle management, blending, filling, logistics, warehousing, and other packaging services. The company operates in three reportable business segments including Global Industrial Packaging, Paper Packaging and Services, and Land Management. It operates in USA, Europe, Middle East, Africa and Asia and Other Americas.

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.

Share on Social Networks: